"Egypt Pharmaceuticals & Healthcare Report Q2 2014" Is Now Available at Fast Market Research
This quarter has seen a number of developments that indicate an increasingly difficult operating environment for local and foreign drugmakers in Egypt. These include suspension of some local drug production, ongoing strikes by doctors and calls for improvements to the registration and pricing regime for pharmaceuticals. Despite its favourable demographic and epidemiological profile, the Egyptian pharmaceutical market has a relatively weak outlook for growth, as economic factors, political uncertainty and lack of regulatory reform obstruct approval and uptake of medicines.
View full press release